Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
This study has been completed.
First Posted: December 15, 2011
Last Update Posted: July 24, 2014
Information provided by (Responsible Party):